STOCK TITAN

questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Quest Diagnostics (NYSE: DGX) has introduced 13 new blood tests on questhealth.com to identify micronutrient deficiencies. These tests are designed for individuals who may have insufficient nutrient intake due to dietary restrictions, prescription medications, or chronic health conditions. The panels, ranging from $65 to $299, cater to specific needs such as food allergies, medication regimens, and chronic diseases like Celiac disease and thyroid disorders.

The tests involve physician oversight and can be purchased directly on questhealth.com. After a physician review, individuals can schedule a blood draw at one of Quest's 2,000+ patient service centers. Results are provided in an easy-to-read report on a secure patient portal, with the option to discuss results with an independent physician at no extra cost.

Quest Diagnostics (NYSE: DGX) ha introdotto 13 nuovi esami del sangue su questhealth.com per identificare le carenze di micronutrienti. Questi esami sono progettati per le persone che possono avere un apporto insufficiente di nutrienti a causa di restrizioni dietetiche, farmaci prescritti o condizioni di salute croniche. I pannelli, che vanno da 65 a 299 dollari, soddisfano esigenze specifiche come allergie alimentari, regimi di medicazione e malattie croniche come la celiachia e i disturbi tiroidei.

Gli esami prevedono supervisione medica e possono essere acquistati direttamente su questhealth.com. Dopo la revisione da parte di un medico, le persone possono pianificare un prelievo di sangue in uno dei oltre 2.000 centri di servizio per pazienti di Quest. I risultati sono forniti in un rapporto facile da leggere su un portale sicuro per i pazienti, con la possibilità di discutere i risultati con un medico indipendente senza costi aggiuntivi.

Quest Diagnostics (NYSE: DGX) ha introducido 13 nuevas pruebas de sangre en questhealth.com para identificar deficiencias de micronutrientes. Estas pruebas están diseñadas para personas que pueden tener una ingesta insuficiente de nutrientes debido a restricciones dietéticas, medicamentos recetados o condiciones de salud crónicas. Los paneles, que van de 65 a 299 dólares, se adaptan a necesidades específicas, como alergias alimentarias, regímenes de medicación y enfermedades crónicas como la enfermedad celíaca y trastornos de la tiroides.

Las pruebas implican supervisión médica y se pueden adquirir directamente en questhealth.com. Después de la revisión de un médico, los individuos pueden programar una extracción de sangre en uno de los más de 2,000 centros de servicio para pacientes de Quest. Los resultados se proporcionan en un informe fácil de entender en un portal seguro para pacientes, con la opción de discutir los resultados con un médico independiente sin costo adicional.

Quest Diagnostics (NYSE: DGX)는 questhealth.com에서 미량 영양소 결핍을 식별하기 위해 13개의 새로운 혈액 검사를 도입했습니다. 이러한 검사는 식이 제한, 처방 약물 또는 만성 건강 상태로 인해 영양소 섭취가 부족할 수 있는 개인을 위해 설계되었습니다. 65달러에서 299달러에 이르는 이 패널은 음식 알레르기, 약물 요법, 그리고 셀리악병과 갑상선 질환과 같은 만성 질병과 같은 특정 요구를 충족시킵니다.

검사는 의사의 감독 하에 이루어지며, questhealth.com에서 직접 구매할 수 있습니다. 의사가 검토한 후, 개인은 Quest의 2,000개 이상의 환자 서비스 센터 중 하나에서 혈액 채취를 예약할 수 있습니다. 결과는 안전한 환자 포털에서 읽기 쉬운 보고서 형식으로 제공되며, 추가 비용 없이 독립된 의사와 결과를 논의할 수 있는 옵션이 있습니다.

Quest Diagnostics (NYSE: DGX) a lancé 13 nouveaux tests sanguins sur questhealth.com pour identifier les carences en micronutriments. Ces tests sont conçus pour les individus qui peuvent avoir une consommation insuffisante de nutriments en raison de restrictions alimentaires, de médicaments sur ordonnance ou de problèmes de santé chroniques. Les panels, allant de 65 à 299 dollars, répondent à des besoins spécifiques tels que les allergies alimentaires, les traitements médicamenteux et les maladies chroniques comme la maladie cœliaque et les troubles de la thyroïde.

Les tests nécessitent une supervision médicale et peuvent être achetés directement sur questhealth.com. Après examen par un médecin, les individus peuvent planifier un prélèvement sanguin dans l'un des plus de 2 000 centres de services aux patients de Quest. Les résultats sont fournis dans un rapport facile à lire sur un portail sécurisé pour les patients, avec la possibilité de discuter des résultats avec un médecin indépendant sans frais supplémentaires.

Quest Diagnostics (NYSE: DGX) hat 13 neue Blutuntersuchungen auf questhealth.com eingeführt, um Mikronährstoffmängel zu identifizieren. Diese Tests sind für Personen gedacht, die aufgrund von diätetischen Einschränkungen, verschreibungspflichtigen Medikamenten oder chronischen Gesundheitszuständen möglicherweise eine unzureichende Nährstoffaufnahme haben. Die Panels, die zwischen 65 und 299 Dollar kosten, richten sich an spezifische Bedürfnisse, wie Nahrungsmittelallergien, Medikation und chronische Erkrankungen wie Zöliakie und Schilddrüsenerkrankungen.

Die Tests erfordern ärztliche Aufsicht und können direkt auf questhealth.com erworben werden. Nach einer ärztlichen Prüfung können die Personen eine Blutabnahme in einem der über 2.000 Patientendienstzentren von Quest planen. Die Ergebnisse werden in einem leicht lesbaren Bericht auf einem sicheren Patientenportal bereitgestellt, mit der Option, die Ergebnisse ohne zusätzliche Kosten mit einem unabhängigen Arzt zu besprechen.

Positive
  • Introduction of 13 new blood tests to identify micronutrient deficiencies
  • Expansion of consumer-initiated testing offerings
  • Physician oversight for all tests, enhancing credibility and safety
  • Nationwide accessibility through 2,000+ patient service centers
  • Option for consumers to discuss results with a physician at no extra cost
Negative
  • None.

Insights

Quest Diagnostics' introduction of 13 new micronutrient deficiency panels is a significant development in consumer-initiated testing. These tests address a important gap in healthcare, targeting individuals with dietary restrictions, medication regimens, or chronic conditions that may lead to nutrient deficiencies. The prevalence of nutrient deficiencies (at least 1 in 3 Americans at risk) underscores the potential market for these tests.

The panels' pricing ($65 to $299) seems competitive, potentially driving adoption. However, the real value lies in the physician oversight and the option for result discussion, which adds credibility and medical value to the service. This move aligns with the growing trend of personalized healthcare and consumer empowerment, potentially positioning Quest favorably in the evolving diagnostic market.

Quest Diagnostics' expansion into consumer-initiated micronutrient testing represents a strategic move to diversify revenue streams. With the global nutritional analysis market projected to grow significantly, this initiative could tap into a lucrative segment. The direct-to-consumer model, coupled with Quest's extensive network of 2,000+ patient service centers, provides a competitive advantage in accessibility and scale.

However, investors should note that the impact on Quest's financials may take time to materialize. The success will depend on consumer adoption rates, marketing effectiveness and potential regulatory challenges. While this move aligns with healthcare trends, it's important to monitor how it fits into Quest's overall growth strategy and its ability to drive long-term value for shareholders.

Lab tests offer insights for individuals who may experience inadequate intake of essential nutrients due to dietary restrictions, certain prescription medications, or chronic health conditions

SECAUCUS, N.J., Aug. 15, 2024 /PRNewswire/ -- Micronutrients are essential vitamins and minerals that are vital for well-being and disease prevention, but deficiencies can commonly be caused by food allergies and dietary restrictions, certain prescription medications, or chronic health conditions. At least one in three Americans are at risk of nutrient deficiencies1. Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the availability of 13 blood tests designed to evaluate micronutrient deficiencies, helping people identify if they are lacking certain vitamins and minerals needed by the body to maintain optimal health. These panels are now available for consumer purchase exclusively at questhealth.com.

These 13 micronutrient deficiency panels are the first consumer-initiated blood-draw tests specifically designed to meet the needs of those who may have insufficient nutrient intake due to certain health factors, including: dietary restrictions influenced by certain food allergies to milk, soy, eggs, tree nuts, and more; prescription medications like oral contraceptives; and chronic health conditions such as Celiac disease and thyroid disorders. Approximately 48.6% of people have used at least one prescription drug in the past 30 days and 60% of Americans live with at least one chronic disease2. Research has linked both prescription medication and chronic health conditions with potential treatment-induced, or disease-state induced, micronutrient deficiencies, respectively.

"Studies have shown that key vitamins and nutrients such as iron, calcium, and magnesium are under-consumed or may be poorly absorbed in the body, which may have an adverse effect on people's health. What people may not realize is that their medications, allergies, chronic conditions and diets can affect how well their bodies can absorb these essential nutrients," said Dr. Katrina Sutton, PharmD, Medical Science Liaison of Consumer-Initiated Testing for questhealth.com. "In providing medically-informed testing solutions and detailed results through our various nutrient panels, we hope to empower people to seek the best pathway to help their overall wellbeing."

Since the COVID-19 pandemic, there continues to be a growing global shift toward greater agency and ownership of personal health. More specifically, these motivations have led many consumers down paths of discovery to unearth factors impacting their overall wellbeing, and many have become more engaged in managing their health. With the introduction of the new micronutrient panels, questhealth.com strives to help individuals identify and seek answers for nutritional concerns as they continue working toward living a proactive, healthy lifestyle.

With the introduction of these new offerings, questhealth.com allows consumers to gain insights into whether their food allergies, medication regimens, or chronic health conditions may be contributing to nutrient deficiencies, including:

  • Dietary restrictions and food allergies:  Milk Allergy Vitamin Deficiency Panel; Wheat Allergy Vitamin Deficiency Panel; and Soy / Tree Nut / Peanut Vitamin Deficiency Panel    
  • Current prescription medications: Oral Contraceptives Vitamin Deficiency Panel; Proton-Pump Inhibitors Vitamin Deficiency Panel; Diuretics Vitamin Deficiency Panel; ACE Inhibitors Vitamin Deficiency Panel; Calcium Channel Blockers Vitamin Deficiency Panel; and Corticosteroids Vitamin Deficiency Panel  
  • Chronic health conditions: Celiac Disease Vitamin Deficiency Panel; Thyroid Disorders Vitamin Deficiency Panel; Depression / Seasonal Depression Vitamin Deficiency Panel; and Inflammatory Bowel Disease (IBD) Vitamin Deficiency Panel

The new consumer-initiated panels range from $65 to $299 and starting today, will begin to roll out on questhealth.com, with additional tests set to debut in the coming weeks. Last year, Quest launched the Vitamin & Nutrition lab test category with an array of diet-specific nutrient deficiency tests catered to those who follow vegetarian/vegan, high-protein, high-fat, and low-carb diet lifestyles, helping consumers better understand if their diets are meeting their unique nutritional needs.

"This expansion underscores our commitment to offering accessible, personalized, and consumer-driven health insights that can make a meaningful difference in our daily lives," said Richard Adams, Senior Vice President and General Manager of Quest Consumer. "Whether micronutrient deficiencies stem from dietary restrictions, medications, or chronic conditions, our tests provide consumers with valuable tools to take better control over their health."

Consumer-Initiated Testing with Physician Oversight
Micronutrient Deficiency Panels are available for individuals to purchase directly on questhealth.com. Unlike traditional direct-to-consumer tests, each of the Quest lab tests available on questhealth.com involve physician oversight. Specifically, when an individual purchases a lab test online, a physician from PWNHealth (an independent, third-party physician network) will review the request and place a lab order. Once the lab order is submitted, an individual can schedule an appointment to visit a nearby Quest Diagnostics location (one of 2,000+ patient service centers across the U.S.) for a blood draw by a trained phlebotomist. Test results are provided in an easy-to-read report on a secure patient portal. Each individual also has the option to discuss their results with an independent physician at no extra cost.

About questhealth.com 
Quest empowers individuals with affordable, high-quality, trusted healthcare. The consumer-initiated test platform, questhealth.com, gives consumers more control over their own healthcare journeys, providing access to the same quality lab tests that doctors use and recommend, offering valuable information and insights about their health. questhealth.com offers more than 100 Quest Diagnostics lab tests in categories ranging from heart health and sexual health to allergies, fitness, and so much more. Consumers must be 18+ to purchase, and orders are not permitted in AK, AZ, or HI. For more information, please visit questhealth.com.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.

1Bird JK, Murphy RA, Ciappio ED, et al. Risk of deficiency in multiple concurrent micronutrients in children and adults in the United States. Nutrients. 2017;9(7):655. doi:10.3390/nu9070655

2Centers for Disease Control and Prevention. (2024, May 15). COVID-19 and chronic disease prevention and interventions. National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP). https://www.cdc.gov/nccdphp/priorities/covid-19.html

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/questhealthcom-introduces-13-new-blood-tests-to-identify-micronutrient-deficiencies-302223361.html

SOURCE Quest Diagnostics

FAQ

What new tests has Quest Diagnostics (DGX) introduced on August 15, 2024?

Quest Diagnostics introduced 13 new blood tests on questhealth.com designed to evaluate micronutrient deficiencies, catering to individuals with dietary restrictions, certain prescription medications, or chronic health conditions.

How much do the new micronutrient deficiency panels from Quest Diagnostics (DGX) cost?

The new consumer-initiated micronutrient deficiency panels from Quest Diagnostics range in price from $65 to $299.

What specific conditions do Quest Diagnostics' (DGX) new micronutrient deficiency panels address?

The new panels address dietary restrictions and food allergies (milk, wheat, soy, tree nuts, peanuts), prescription medications (oral contraceptives, proton-pump inhibitors, diuretics, ACE inhibitors, calcium channel blockers, corticosteroids), and chronic health conditions (Celiac disease, thyroid disorders, depression, inflammatory bowel disease).

How can consumers access Quest Diagnostics' (DGX) new micronutrient deficiency tests?

Consumers can purchase the tests directly on questhealth.com. After physician review, they can schedule a blood draw at one of Quest's 2,000+ patient service centers across the U.S.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

16.99B
111.10M
0.43%
91.55%
2.32%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SECAUCUS